search
Back to results

TRAUMEEL S in Reducing Pain After Correction of Hallux Valgus-Clinical Trial

Primary Purpose

Post Hallux Valgus Repair Pain

Status
Completed
Phase
Phase 3
Locations
Israel
Study Type
Interventional
Intervention
Traumeel S
Sponsored by
Shaare Zedek Medical Center
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Post Hallux Valgus Repair Pain focused on measuring homeopathy, hallux valgus, pain, traumeel s

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patients of either sex undergoing unilateral surgical correction of Hallux Valgus. Age over 18 years. Signature upon informed consent form. Meeting none of exclusion criteria. Exclusion criteria Participation in another clinical trial within 4 weeks prior to enrollment. Inability to comply with the study protocol. Previous surgical Hallux Valgus correction on ipsilateral foot. Current use of analgesia for any other reason.

Sites / Locations

  • Dept. of Orthopedic Surgery, Shaare Zedek Medical Center

Outcomes

Primary Outcome Measures

Pain

Secondary Outcome Measures

Analgesics consumed
Days of "rescue" analgesic use
Area of redness
The safety treatment

Full Information

First Posted
January 9, 2006
Last Updated
April 3, 2011
Sponsor
Shaare Zedek Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00279513
Brief Title
TRAUMEEL S in Reducing Pain After Correction of Hallux Valgus-Clinical Trial
Official Title
A Randomised, Double- Blind, Placebo Controlled, Clinical Trial to Assess the Efficacy of the Homeopathic Medication TRAUMEEL S in Reducing Pain After Surgical Correction of Hallux Valgus
Study Type
Interventional

2. Study Status

Record Verification Date
April 2011
Overall Recruitment Status
Completed
Study Start Date
September 2006 (undefined)
Primary Completion Date
December 2007 (Actual)
Study Completion Date
December 2007 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Shaare Zedek Medical Center

4. Oversight

5. Study Description

Brief Summary
Hallux valgus is a common deformity of the big toe, defined as medial deflection of the first metatarsal bone along with lateral deflection of the first toe. Surgery has been shown to be beneficial when compared to orthoses or no treatment. While generally effective, surgery entails significant post-operative pain, inflammation and edema, and several weeks of limited mobility. This will be a double-blind, randomized, placebo-controlled study comparing the homeopathic drug Traumeel S with placebo in pain reduction after surgical Hallux valgus correction. 80 patients, over the age of 18 years, undergoing surgical correction of unilateral hallux valgus will be enrolled in the trial. The patients will be randomized to two groups, one receiving oral Traumeel S and the other oral placebo tablets. Patients will take active or placebo medication for 13 days or until they have a NRS score of 3 or less for 2 consecutive days. Pain will be reported daily by the patient on the patient diary, using an 11-point numerical rating score (NRS-11) during 13 days post-operatively. They will also be asked to report daily consumption of primary and "rescue" analgesics for 13 days post-operatively. Patients will be contacted daily by the research assistant to encourage compliance and to record their daily NRS and analgesic consumption in the CRF. Patients will be evaluated by physicians at six and 13 days postoperatively for redness and compliance.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Post Hallux Valgus Repair Pain
Keywords
homeopathy, hallux valgus, pain, traumeel s

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Traumeel S
Primary Outcome Measure Information:
Title
Pain
Secondary Outcome Measure Information:
Title
Analgesics consumed
Title
Days of "rescue" analgesic use
Title
Area of redness
Title
The safety treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients of either sex undergoing unilateral surgical correction of Hallux Valgus. Age over 18 years. Signature upon informed consent form. Meeting none of exclusion criteria. Exclusion criteria Participation in another clinical trial within 4 weeks prior to enrollment. Inability to comply with the study protocol. Previous surgical Hallux Valgus correction on ipsilateral foot. Current use of analgesia for any other reason.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Menachem Oberbaum, M.D.
Organizational Affiliation
Shaare Zedek Medical Center, Jerusalem, Israel
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dept. of Orthopedic Surgery, Shaare Zedek Medical Center
City
Jerusalem
ZIP/Postal Code
91031
Country
Israel

12. IPD Sharing Statement

Citations:
PubMed Identifier
20380750
Citation
Singer SR, Amit-Kohn M, Weiss S, Rosenblum J, Maoz G, Samuels N, Lukasiewicz E, Freedman L, Paltiel O, Itzchaki M, Niska M, Oberbaum M. Traumeel S for pain relief following hallux valgus surgery: a randomized controlled trial. BMC Clin Pharmacol. 2010 Apr 12;10:9. doi: 10.1186/1472-6904-10-9.
Results Reference
derived

Learn more about this trial

TRAUMEEL S in Reducing Pain After Correction of Hallux Valgus-Clinical Trial

We'll reach out to this number within 24 hrs